Literature DB >> 18784229

Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria.

Sasithon Pukrittayakamee1, Mallika Imwong, Pratap Singhasivanon, Kasia Stepniewska, Nicholas J Day, Nicholas J White.   

Abstract

The gametocytocidal and asexual stage activities of eight antimalarial and eight antibiotic-containing regimens were evaluated in 349 adult patients with P. vivax malaria. Gametocytemia was found in 63% of patients (22% before and 41% after treatment). The median (range) gametocyte clearance time was 24 hours (range, 2-504 hours) and correlated with asexual parasite clearance time (r = 0.52, P < 0.001). Gametocytemia in vivax malaria was more common in patients with admission parasitemia > 10,000/microL and after treatment with drugs which have weak antimalarial activity, and was also associated with an increased rate of vivax reappearance (29.4% versus 14.1%, P = 0.002). Sexual stage activities corresponded with asexual stage activity for all tested regimens. Treatment with potent antimalarial drugs reduces the transmission potential of P. vivax.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18784229

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  26 in total

Review 1.  Resistance to therapies for infection by Plasmodium vivax.

Authors:  J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 2.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

3.  Appropriate time for primaquine treatment to reduce Plasmodium falciparum transmission in hypoendemic areas.

Authors:  Polrat Wilairatana; Srivicha Krudsood; Noppadon Tangpukdee
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

4.  Therapeutic responses of Plasmodium vivax malaria to chloroquine and primaquine treatment in northeastern Myanmar.

Authors:  Lili Yuan; Ying Wang; Daniel M Parker; Bhavna Gupta; Zhaoqing Yang; Huaie Liu; Qi Fan; Yaming Cao; Yuping Xiao; Ming-chieh Lee; Guofa Zhou; Guiyun Yan; J Kevin Baird; Liwang Cui
Journal:  Antimicrob Agents Chemother       Date:  2014-12-15       Impact factor: 5.191

5.  Suppressive effect of azithromycin on Plasmodium berghei mosquito stage development and apicoplast replication.

Authors:  Shoichi Shimizu; Yoshio Osada; Tamotsu Kanazawa; Yoshiya Tanaka; Meiji Arai
Journal:  Malar J       Date:  2010-03-10       Impact factor: 2.979

6.  Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.

Authors:  Rie Takeuchi; Saranath Lawpoolsri; Mallika Imwong; Jun Kobayashi; Jaranit Kaewkungwal; Sasithon Pukrittayakamee; Supalap Puangsa-art; Nipon Thanyavanich; Wanchai Maneeboonyang; Nicholas P J Day; Pratap Singhasivanon
Journal:  Malar J       Date:  2010-11-01       Impact factor: 2.979

7.  Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon.

Authors:  Shira R Abeles; Raul Chuquiyauri; Carlos Tong; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

8.  Plasmodium vivax: reverse transcriptase real-time PCR for gametocyte detection and quantitation in clinical samples.

Authors:  Nathália F Lima; Melissa S Bastos; Marcelo U Ferreira
Journal:  Exp Parasitol       Date:  2012-08-24       Impact factor: 2.011

Review 9.  Operational strategies to achieve and maintain malaria elimination.

Authors:  Bruno Moonen; Justin M Cohen; Robert W Snow; Laurence Slutsker; Chris Drakeley; David L Smith; Rabindra R Abeyasinghe; Mario Henry Rodriguez; Rajendra Maharaj; Marcel Tanner; Geoffrey Targett
Journal:  Lancet       Date:  2010-10-28       Impact factor: 79.321

10.  Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis.

Authors:  Kathrine R Tan; Alan J Magill; Monica E Parise; Paul M Arguin
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.